跳至主要内容
临床试验/NCT01004718
NCT01004718已完成不适用

A Pilot Study to Assess the Feasibility of Detection and Quantification of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using FDG-PET/CT Imaging

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2009年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Percentage Change in Maximum Lesional FDG Uptake From 60 to 180 Minutes After FDG Administration

研究概览

简要总结

RATIONALE: Imaging procedures, such as positron emission tomography or computed tomography, may help in detecting differences between Hodgkin lymphoma or diffuse large B-cell lymphoma cancer cells. PURPOSE: This clinical trial is studying positron emission tomogaphy and computed tomography in determining differences in Hodgkin lymphoma and diffuse large B-cell lymphoma.

详细描述

OBJECTIVES:

I. Assess the feasibility of detection and quantification of differences in the temporal and spatial distribution of FDG uptake between lesions of HL and DLBCL.

OUTLINE:

Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans 60 and 180 minutes after FDG administration.

After completion of study, patients are followed for 24 hours.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subjects with a pathologically-proven diagnosis of classic HL or DLBCL with measurable disease by any imaging technique or physical examination.

排除标准

  • •Pregnant or nursing,
  • •Uncontrolled diabetes mellitus,
  • •Active infection,
  • •Inability to give informed consent or to comply with all study procedures,
  • •Subjects may be excluded at the discretion of the principal investigator or study team members.

研究组 & 干预措施

Fludeoxyglucose F18 (FDG) PET/CT scans

Experimental

Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans and 180 minutes after FDG administration.

干预措施: Computed Tomography (Procedure)

Fludeoxyglucose F18 (FDG) PET/CT scans

Experimental

Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans and 180 minutes after FDG administration.

干预措施: Positron emission tomography (Procedure)

Fludeoxyglucose F18 (FDG) PET/CT scans

Experimental

Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans and 180 minutes after FDG administration.

干预措施: Fludeoxyglucose F18 (Radiation)

结局指标

主要结局

Percentage Change in Maximum Lesional FDG Uptake From 60 to 180 Minutes After FDG Administration

时间窗: 2 hours (between 60 minutes post-administration and 180 minutes post-administration)

Lesional fluorodeoxyglucose (FDG) uptake is measured by standardized uptake value (SUV). The study compared the percentage of change in maximum SUV over 2 hours (first measure was 60 minutes post-administration and second timepoint was 180 minutes post-administration).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验